These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26553068)

  • 21. Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
    Circu M; Cardelli J; Barr MP; O'Byrne K; Mills G; El-Osta H
    PLoS One; 2017; 12(9):e0184922. PubMed ID: 28945807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term stimulation of areca nut components results in increased chemoresistance through elevated autophagic activity.
    Yen CY; Chiang WF; Liu SY; Cheng PC; Lee SY; Hong WZ; Lin PY; Lin MH; Liu YC
    J Oral Pathol Med; 2014 Feb; 43(2):91-6. PubMed ID: 23795940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1.
    Ma Y; Li X; Cheng S; Wei W; Li Y
    Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways.
    Wang Y; Qiu Q; Shen JJ; Li DD; Jiang XJ; Si SY; Shao RG; Wang Z
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1813-24. PubMed ID: 22750415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells.
    Zhou GZ; Zhang SN; Zhang L; Sun GC; Chen XB
    Pharm Biol; 2014 Jan; 52(1):111-6. PubMed ID: 24044367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin.
    Shin DH; Choi YJ; Park JW
    Cancer Res; 2014 Jan; 74(1):298-308. PubMed ID: 24240701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
    Zhang Y; Cheng Y; Ren X; Zhang L; Yap KL; Wu H; Patel R; Liu D; Qin ZH; Shih IM; Yang JM
    Oncogene; 2012 Feb; 31(8):1055-64. PubMed ID: 21743489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The triazole linked galactose substituted dicyano compound can induce autophagy in NSCLC cell lines.
    Alvur O; Tokgun O; Baygu Y; Kabay N; Gok Y; Akca H
    Gene; 2019 Sep; 712():143935. PubMed ID: 31247220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.
    Wang M; Liu ZM; Li XC; Yao YT; Yin ZX
    J Chemother; 2013 Jun; 25(3):162-9. PubMed ID: 23783141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilms' tumor 1 enhances Cisplatin-resistance of advanced NSCLC.
    Wu C; Wang Y; Xia Y; He S; Wang Z; Chen Y; Wu C; Shu Y; Jiang J
    FEBS Lett; 2014 Dec; 588(24):4566-72. PubMed ID: 25447528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.
    Lee JG; Wu R
    PLoS One; 2012; 7(10):e48532. PubMed ID: 23119048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.
    Puissant A; Robert G; Fenouille N; Luciano F; Cassuto JP; Raynaud S; Auberger P
    Cancer Res; 2010 Feb; 70(3):1042-52. PubMed ID: 20103647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of high mobility group box-1 in chemo-sensitivity in cervical cancer].
    Zhu F; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 43(1):14-21. PubMed ID: 30154286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
    Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
    Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of ADAM8 against cisplatin-mediated apoptosis in non-small-cell lung cancer.
    Zhang W; Wan M; Ma L; Liu X; He J
    Cell Biol Int; 2013 Jan; 37(1):47-53. PubMed ID: 23319321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia induces autophagy in PA-l ovarian teratoma cells and resistance to growth inhibition and apoptosis by chemotherapeutic agent cis-diamminedichloroplatinum.
    Chen CD; Dai LN; Wang M; Lai XH; Wang J
    Eur J Gynaecol Oncol; 2017; 38(2):277-281. PubMed ID: 29953795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.
    Cortés-Sempere M; de Miguel MP; Pernía O; Rodriguez C; de Castro Carpeño J; Nistal M; Conde E; López-Ríos F; Belda-Iniesta C; Perona R; Ibanez de Caceres I
    Oncogene; 2013 Mar; 32(10):1274-83. PubMed ID: 22543588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.